Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase 2

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

zoliflodacin (ETX0914) / Global Antibiotic Research and Development Partnership, Innoviva

NCT02257918: Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea

Completed

180

AZD0914, Ceftriaxone

National Institute of Allergy and Infectious Diseases (NIAID)

Gonorrhoea

12/15

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites